Benefits of a dermocosmetic regimen in the management of local skin intolerance induced by a retinoid-based acne gel previously inadequately mitigated with routine adjunctive skin care

Retinoid-based topical acne treatment may induce local tolerance issues such as erythema, dryness, stinging and burning sensations that may reduce treatment adherence and its efficacy. The tested dermocosmetic (DC) regimen has been specifically developed to improve acne treatment-related local side effects. The DC cream contains maltodextrine and Bixa Orellana seed extract, a new plant derivative that reduces sebum production and hyperkeratinisation, along with niacinamide, panthenol and the post-biotic Aqua Posae Filiformis (APF) to improve skin barrer and decrease inflammation. The DC cleanser contains maltodextrine and Bixa Orellana seed extract, niacinamide, APF, mannose and citric acid.